BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 32640634)

  • 1. Identification of GSN and LAMC2 as Key Prognostic Genes of Bladder Cancer by Integrated Bioinformatics Analysis.
    Yang JL; Wang CCN; Cai JH; Chou CY; Lin YC; Hung CC
    Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32640634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of Prognostic Candidate Genes in Breast Cancer by Integrated Bioinformatic Analysis.
    Wang CCN; Li CY; Cai JH; Sheu PC; Tsai JJP; Wu MY; Li CJ; Hou MF
    J Clin Med; 2019 Aug; 8(8):. PubMed ID: 31382519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fifteen hub genes associated with progression and prognosis of clear cell renal cell carcinoma identified by coexpression analysis.
    Wang Y; Chen L; Wang G; Cheng S; Qian K; Liu X; Wu CL; Xiao Y; Wang X
    J Cell Physiol; 2019 Jul; 234(7):10225-10237. PubMed ID: 30417363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of key genes for predicting colorectal cancer prognosis by integrated bioinformatics analysis.
    Dai GP; Wang LP; Wen YQ; Ren XQ; Zuo SG
    Oncol Lett; 2020 Jan; 19(1):388-398. PubMed ID: 31897151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of prognostic markers of high grade prostate cancer through an integrated bioinformatics approach.
    Huang H; Zhang Q; Ye C; Lv JM; Liu X; Chen L; Wu H; Yin L; Cui XG; Xu DF; Liu WH
    J Cancer Res Clin Oncol; 2017 Dec; 143(12):2571-2579. PubMed ID: 28849390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-expression Network Analysis of Biomarkers for Adrenocortical Carcinoma.
    Yuan L; Qian G; Chen L; Wu CL; Dan HC; Xiao Y; Wang X
    Front Genet; 2018; 9():328. PubMed ID: 30158955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel Biomarkers Associated With Progression and Prognosis of Bladder Cancer Identified by Co-expression Analysis.
    Wang Y; Chen L; Ju L; Qian K; Liu X; Wang X; Xiao Y
    Front Oncol; 2019; 9():1030. PubMed ID: 31681575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PLAU and LAMC2 can predict a poor prognosis in patients with HNSCC.
    Guo ZC; Jing SL; Cui H; Xie LY; Na SJ; Tu JB
    J Cancer; 2023; 14(9):1660-1672. PubMed ID: 37325056
    [No Abstract]   [Full Text] [Related]  

  • 9. Weighted Gene Coexpression Network Analysis of Features That Control Cancer Stem Cells Reveals Prognostic Biomarkers in Lung Adenocarcinoma.
    Liao Y; Wang Y; Cheng M; Huang C; Fan X
    Front Genet; 2020; 11():311. PubMed ID: 32391047
    [No Abstract]   [Full Text] [Related]  

  • 10. Prognostic Genes of Breast Cancer Identified by Gene Co-expression Network Analysis.
    Tang J; Kong D; Cui Q; Wang K; Zhang D; Gong Y; Wu G
    Front Oncol; 2018; 8():374. PubMed ID: 30254986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gelsolin, an Actin-Binding Protein: Bioinformatic Analysis and Functional Significance in Urothelial Bladder Carcinoma.
    Alsofyani AA; Nedjadi T
    Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of Hub Genes Associated With Development of Head and Neck Squamous Cell Carcinoma by Integrated Bioinformatics Analysis.
    Li CY; Cai JH; Tsai JJP; Wang CCN
    Front Oncol; 2020; 10():681. PubMed ID: 32528874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Weighted gene co-expression network analysis of the association between upregulated AMD1, EN1 and VGLL1 and the progression and poor prognosis of breast cancer.
    Yang L; Li X; Luo Y; Yang T; Wang H; Shi L; Feng M; Xie W
    Exp Ther Med; 2021 Sep; 22(3):1030. PubMed ID: 34373716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LAMC2 as a prognostic biomarker in human cancer: a systematic review and meta-analysis.
    Fu T; Liu JX; Xie J; Gao Z; Yang Z
    BMJ Open; 2022 Nov; 12(11):e063682. PubMed ID: 36396303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Co-expression network analysis identified six hub genes in association with progression and prognosis in human clear cell renal cell carcinoma (ccRCC).
    Yuan L; Chen L; Qian K; Qian G; Wu CL; Wang X; Xiao Y
    Genom Data; 2017 Dec; 14():132-140. PubMed ID: 29159069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Biomarkers Related to Prognosis of Bladder Transitional Cell Carcinoma.
    Liu Z; Xu L; Lin Y; Hong H; Wei Y; Ye L; Wu X
    Front Genet; 2021; 12():682237. PubMed ID: 34434217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of Lymph Node Metastasis-Related Key Genes and Prognostic Risk Model in Bladder Cancer by Co-Expression Analysis.
    Luo C; Huang B; Wu Y; Xu Y; Ou W; Chen J; Chen L
    Front Mol Biosci; 2021; 8():633299. PubMed ID: 34368222
    [No Abstract]   [Full Text] [Related]  

  • 18. Identification of key genes involved in the development and progression of early-onset colorectal cancer by co-expression network analysis.
    Mo X; Su Z; Yang B; Zeng Z; Lei S; Qiao H
    Oncol Lett; 2020 Jan; 19(1):177-186. PubMed ID: 31897128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Weighted Gene Co-Expression Network Analysis Identifies Hub Genes Associated with Occurrence and Prognosis of Oral Squamous Cell Carcinoma.
    Ge Y; Li W; Ni Q; He Y; Chu J; Wei P
    Med Sci Monit; 2019 Sep; 25():7272-7288. PubMed ID: 31562292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Four novel biomarkers for bladder cancer identified by weighted gene coexpression network analysis.
    Yan X; Guo ZX; Liu XP; Feng YJ; Zhao YJ; Liu TZ; Li S
    J Cell Physiol; 2019 Aug; 234(10):19073-19087. PubMed ID: 30927274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.